Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative
LONDON and PITTSBURGH, Dec. 4, 2014 /PRNewswire/ -- Mylan Inc.
Mylan receives tentative FDA approval for pediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative
PITTSBURGH and LONDON, Dec. 4, 2014 /PRNewswire/ -- Mylan Inc.
FDA issues final rule on changes to pregnancy and lactation labeling information for prescription drug and biological products
Teva Receives Positive Outcome in Europe for Three-Times-a-Week COPAXONE® (Glatiramer Acetate) 40 mg/ml for the Treatment of Relapsing Forms of Multiple Sclerosis (RMS)
<0> Teva Pharmaceutical Industries Ltd.IR:United States, 215-591-8912, 215-591-3033orIsrael, 972 (3) 926-7656orPR:Israel, 972 (3) 926-7687orUnited States, 215-591-8974, 215-284-0213 </0>
Actress Adamari López And Amgen Launch Spanish-Language Chemotherapy: Myths Or Facts™ Website And Resources
Quimioterapia: Mitos y Realidades Aimed at Helping Spanish-Speaking Patients and Caregivers Take Control of Their Chemotherapy Journey
FDA Approves BLINCYTO™ (Blinatumomab) Immunotherapy for the Treatment of Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
BLINCYTO is the First-and-Only Bispecific CD19-Directed CD3 T-Cell Engager (BiTE®) Immunotherapy to be Approved by the FDA
XTANDI™ (enzalutamide) Now Approved in Europe for the Treatment of Men with Metastatic Castration-Resistant Prostate Cancer Who Are Chemotherapy-Naïve
SAN ANTONIO, Dec. 2, 2014 /PRNewswire/ -- GenSpera, Inc.
NICE draft guidance recommends eculizumab (Soliris) for treating very rare life-threatening blood disorder
Eli Lilly and Company and AstraZeneca Initiate Pivotal Clinical Trial for Patients with Early Alzheimer's Disease
Phase II/III trial of AZD3293, an oral potent small molecule inhibitor of BACE, aims to enroll more than 1,500 patients in 15 countries
Merck's HIV Education Campaign, I Design, Reveals Video and Poem Created by the HIV Community in Honor of World AIDS Day
Collective Voice of Community Embodies Culmination of "Getting Vocal" About Individualized Treatment around the Country
New IMBRUVICA® (ibrutinib) Application Accepted by European Medicines Agency for Waldenstrom's Macroglobulinemia
Filing completed less than two months after first European approval for IMBRUVICA®
SUNNYVALE, Calif., Dec.
Australian Diabetes Management Market and Diabetes Diagnostic Devices Market Spurted by $46 Million Between 2005 and 2013
LONDON and NEW YORK, December 1, 2014 /PRNewswire/ --